NCT00443937 Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients Status COMPLETED Phase PHASE4
NCT00436618 Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment Status COMPLETED Phase PHASE2
NCT00434174 Safety of Everolimus and Pemetrexed in Lung Cancer Patients Status COMPLETED Phase PHASE1
NCT00426556 Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00426049 Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation Status UNKNOWN Phase PHASE3
NCT00423865 Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00414440 Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease Status COMPLETED Phase PHASE4
NCT00412061 Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor Status COMPLETED Phase PHASE3
NCT00411619 Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex Status COMPLETED Phase PHASE1/PHASE2
NCT00402662 A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma Status TERMINATED Phase PHASE2
NCT00402532 Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation Status COMPLETED Phase PHASE3
NCT00390364 Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy Status TERMINATED Phase PHASE2
NCT00387400 Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00378014 Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy Status COMPLETED Phase PHASE3
NCT00377962 Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation Status COMPLETED Phase PHASE4
NCT00373815 Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease Status TERMINATED Phase PHASE1
NCT00352443 S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00332839 Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients. Status TERMINATED Phase PHASE4
NCT00331409 Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer Status COMPLETED Phase PHASE2